Survodutide
Survodutide is a dual agonist of the glucagon receptor and the glucagon-like peptide-1 receptor. It was developed to treat MASH, a condition that can cause cirrhosis. It may also improve other liver-related conditions by reducing liver fat, fibrosis, and stiffness.
Weight loss: Survodutide can help with weight loss, including in people with obesity.
Heart health: Survodutide may improve heart health, including blood pressure and waist circumference.
Survodutide is a dual agonist of the glucagon receptor and the glucagon-like peptide-1 receptor. It was developed to treat MASH, a condition that can cause cirrhosis. It may also improve other liver-related conditions by reducing liver fat, fibrosis, and stiffness.
Weight loss: Survodutide can help with weight loss, including in people with obesity.
Heart health: Survodutide may improve heart health, including blood pressure and waist circumference.
Survodutide is a dual agonist of the glucagon receptor and the glucagon-like peptide-1 receptor. It was developed to treat MASH, a condition that can cause cirrhosis. It may also improve other liver-related conditions by reducing liver fat, fibrosis, and stiffness.
Weight loss: Survodutide can help with weight loss, including in people with obesity.
Heart health: Survodutide may improve heart health, including blood pressure and waist circumference.
These products are designated solely for research purposes only and is not intended for human consumption. These products are expressly tailored for laboratory inquiries, comprising both in vitro assessments and in vivo animal experiments, to be conducted exclusively by trained professionals. Compliance with all relevant regulations and directives is essential in the handling and deployment of these items. By acquiring these goods, you commit to their utilization strictly in conformity with prevailing regulations and solely for legitimate research purposes. Any unauthorized or improper usage of these products is explicitly prohibited.